Chat IA

Oaktree Specialty Lending Corporation

OCSL · NasdaqGS · USD

12.71 +0.04 (0.32%)

Al cierre: Sep 11, 2026, 3:59 PM

12.58 -1.02%

Fuera de horario: 5:23 PM

Volumen
446K

Oaktree Specialty Lending Corporation (OCSL): cotización, análisis y datos

Valor intrínseco

Cargando valor intrínseco…

Pronóstico del analista

Previsiones bursátiles →

Precio objetivo

$11,50 – $13,50

mediana $12,50 · 1.65% Potencial bajista

Objetivo a 12 meses · 6 analistas

Consenso de analistas: n/a

Intervalo:1D
Cargando velas y señales…

Desempeño financiero

Ver finanzas →

Cargando...

Últimos resultados

ReportadoVs. estimaciónCambio interanual
Ingresos$34.55Mn/a-5.06%
EPS$0,37+$0,010.00%

Próximos resultados

antes de que se abra el mercado.

Estimar · Actualizar →

Ver detalles de resultados →

Métricas

Precio de compra
9.17
Beneficio neto (TTM)
42.2M
0.57
0.48
26.48
9.3
P/B (TTM)
0.81
P/S (TTM)
3.83
Fecha de resultados
Nov 17, 2026
Precio de venta
12.7
Volumen
445,847
Volumen medio (20D)
526,490
Abierto
12.73
Anterior Cerrar
12.67
Rango del día
12.65 - 12.80
Rango de 52 semanas
10.63 - 14.31
Precio objetivo
12.5 (-1.65%)
Dividendos
$1.32 (10.42%)
Fecha ex dividendo
Sep 15, 2026

Acerca de Oaktree Specialty Lending Corporation

Ver perfil →
Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies. Asset Management · Financial Services

Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.

IPO Fecha Jun 12, 2008
Empleados n/a
Bolsa de Valores NasdaqGS
Símbolo bursátil OCSL